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ABSTRACT
Stargardt disease-4 (STGD4) is an autosomal dominant complex, genetically
heterogeneous macular degeneration/dystrophy (MD) disorder. In this paper, we
used targeted next generation sequencing and multiple molecular dynamics analyses
to identify and characterize a disease-causing genetic variant in four generations
of a Chinese family with STGD4-like MD. We found a novel heterozygous missense
mutation, c.734T>C (p.L245P) in the PROM1 gene. Structurally, this mutation most
likely impairs PROM1 protein stability, flexibility, and amino acid interaction network
after changing the amino acid residue Leucine into Proline in the basic helix-loophelix leucine zipper domain. Molecular dynamic simulation and principal component
analysis provide compelling evidence that this PROM1 mutation contributes to disease
causativeness or susceptibility variants in patients with STGD4-like MD. Thus, this
finding defines new approaches in genetic characterization, accurate diagnosis, and
prevention of STGD4-like MD.

INTRODUCTION
Stargardt

disease

(STGD)

www.impactjournals.com/oncotarget

is

a

heterogeneous juvenile-onset macular degeneration/
dystrophy (MD) disease with an estimated incidence of
10-12.5 per 100,000 people [1, 2]. Clinically, STGD is

common,
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usually characterized by decreased central vision, night
blindness, mildl atrophy of the macular photoreceptor
cells, underlying retinal pigment epithelium, and gradual
appearance of fundus flecks in the posterior pole of the
retina [3]. This STGD disease is mostly inherited as an
autosomal recessive trait of STGD (arSTGD) while
Stargardt disease-4 (STGD4) is an autosomal dominant
trait (adSTGD), which is associated with mutations in
various genes. STGDs are mutagenetically categorized
in three types/genes: ABCA4 gene mutation (1p22.1)
(STGD1 [MIM248200]) [4-6], ELOVL4 gene mutation
(6q14.1) (STGD3 [MIM600110]) [2, 7, 8], and PROM1
gene mutation (4p15.32) (STGD4 [MIM603786]) [9-11].
Most recent families of MD and adSTGD-like genes were
mapped and described in the STGD4 locus of patients with
retinitis pigmentosa (RP) [10, 12].
PROM1 (Gene ID: 8842, also named as PROML1,
CD133 and AC133) encodes prominin (mouse)-like
1 protein Prominin-1 containing 97 kDa protein with
865-amino acid. As a topic glycoprotein, PROM1
constitutes a 5-transmembrane domain glycoprotein with
two short N (extracellular)- and C (cytoplasmic)-terminal
tails and two large N-glycosylated extracellular loops in
both rod and cone photoreceptor cells. Prominin-1 has
been expressed originally in ependymal cells, human
fetal spinal cords, and the oligodendroglia [13, 14] and is
a well characterized biomarker of normal and cancerous
stem cells in the central nervous system [15]. PROM1 is
positioned at the apical surface of retinoblastoma cell lines
and adult retina [16, 17]. Current scientific literatures have
indicated that the PROM1 is likely to be involved in the
protrusion, organization, and cholesterol composition of
the plasma membrane [18]. In addition, PROM1 plays
crucial roles in the biogenesis of photoreceptor rod discs
concentrated in plasma membrane evaginations of the
nascent disc membranes. Mutations in the PROM1 gene
have also been reported in other MD diseases, such as
STGD4 [10, 12, 19] and cone-rod dystrophy [9-11], which
demonstrates that mutations in same gene may manifest
multiple clinical phenotypes.
In STGD4-like MD, defective PROM1 is similarly
involved in plasma membrane invaginations and disk
malfunction, particularly in the myoid region of the
photoreceptor [10, 20]. In the photoreceptor cells of
STGD4-like MD, PROM1 cannot be migrated into
the outer segment where disks are formed, leading to
disk malfunction and vision problem [21]. Even with
developing knowledge, the function and mediator roles
of PROM1 in MD disease are not well characterized.
Despite numerous genetic studies focused on identifying
of PROM1 mutation (mainly frameshift) in Pakistani
[20], Saudi Arabian [22], Spanish [9], and Indian [18]
families with MD degeneration, the molecular roles of
these mutations are still obscure. An interesting area to
continue research is the specific mechanism of mutations
on the PROM1 gene in the disk morphogenesis, as well as
www.impactjournals.com/oncotarget

how this misallocation of disks in photoreceptors could be
transmitted as an autosomal dominant trait and/or as an
autosomal recessive trait.
In this study, we considered a Chinese family with
STGD4-like MD that has a novel, deleterious, pathogenic
and disease-causing mutation, c.734T > C (p.L245P), in
the PROM1 gene. The structural, molecular dynamics
and energetic analysis of the wild and mutational types
of PROM1 gave us a clear overview of the fundamental
process at the molecular level. A combination of
molecular dynamic simulations and principal component
analysis (PCA) is applied to investigate the molecular
mechanism of the mutation’s conformational diversity.
Free energy landscapes (FEL) based on trajectories of
the simulation also provide detailed information related
to be conformational changes of proteins. Thus, FEL
using multiple physical parameters from the molecular
simulation trajectory are calculated to reveal related
energetic information of the mutation’s conformational
diversity.

RESULTS
Pedigree information and clinical findings
A four-generation pedigree (M107, proband: II: 2)
of a Chinese family, in which one or more members have
a mixed retinal dystrophy, was created in the study (Figure
1A). The proband, 63 years old women, claimed to have
issues with sight ever since the age of 42 with bilateral
Bull’s eye maculopathy. The images of the proband
are documented by fundus photography (FP), fundus
autofluorescence (FA), electroretinograms (ERGs), and
optical coherence tomography (OCT), which are shown in
Figure 1B-1G, respectively. As the FA results illustrated,
the absence of a normal darkened presence, replacement
of a central reddish orange hue and close mottling
(especially in the left eye, Figure 1B-1C), bilateral macular
discoloration, and peripheral mottling with intraretinal
pigment clumping (especially in the right eye, Figure 1D1E) are major abnormalities in the retinal examination.
The FA showed dark choroid with limited staining of some
white fundus flecks in both eyes. Our results revealed
possible chorioretinal atrophy in the right eye, which is
highlighted by perifoveal and parafoveal hypofluorescent
(Figure 1E). The outer retinal architecture in left and right
eyes was lost, respectively (Figure 1F-1G), which was
extremely apparent in the macula. Importantly, macular
progressive depigmentation with pigment clumping and
atrophy is a major complement of the proband.
Other patients showed similar clinical and
ophthalmological abnormalities. Tunnel vision and loss
of peripheral vision were apparent in all patients. The
presenting symptoms for proband and pedigree II:6 were
123
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Figure 1: Pedigree of the M107 family with autosomal dominant Stargardt4-like macular dystrophy and clinical
assessment of affected proband. A. Pedigree of the M107 family. Family number and disease-causing mutation (s) are noted at this

pedigree. Normal individuals are shown as clear circles (females) and squares (males), affected individuals are shown as filled symbols.
The patient above the arrow indicates proband (II: 2) (molecular no.: M107). Individuals with heterozygous mutation are represented in
filled symbols. Targeted next generation sequencing individual indicated with arrow. B., D. Fundus photography of the left and right eyes,
respectively. C., E. Fundus autofluorescences of left and right eyes, respectively. F., G. OCT characterization of the left and right eyes
with conclusive genetic defects, respectively. The macular progressive depigmentation with atrophy and pigment clumping are major
complement of proband.
www.impactjournals.com/oncotarget
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Table 1: Characteristics of PROM1 SNP in Chinese family with adSTGD and analysis of their predicted protein
structure and disease-causing effects.
Variation
Exon
Polyphen-2 Mutation
I-Mutant3.0
SIFT
EXAC
Taster
Nucleotide* Protein* Type
Status
7

c.734 T>C

P.L245P Missense Heter

PD (1.000)

DC (98)

DS (-1.59 kcal/mol) D (0.01) Novel

Abbreviations: c, variation at cDNA level; p, variation at protein level; L245P, Proline substitution conserved leucine at codon
245; Heter, heterozygote; PD, probably damaging; DC, disease causing; DS, Decrease stability; D, damaging.
* All nucleotide and amino acid abbreviated according the International Union of Pure and Applied Chemistry (IUPAC). 

The predictions of conservation and damage
in the c.734T > C (p.L245P) mutation on the
PROM1 protein

more severe, especially in night blindness. Based on our
pedigree analysis in the proband, there were decreased
central vision and visual acuity, and a prominent presence
of fundus flecks in the posterior pole of the retina, which
demonstrated a late onset STGD4-like MD. Neither
STGD4-like MD nor MD-related ophthalmological
defects was observed in other recruited normal family
members.

The PROM1 protein alignment analysis based on
multiple sequence alignment in different organisms’ genes
is shown in the Supplementary Figure S1. The nucleotide
change results in a Pro substitution for a highly conserved
Leu at residue 245 (p.L245P). The PROM1 p.L245P
mutation in a basic helix-loop-helix leucine zipper domain
(bHLH-Zip) indicates an important role in transcriptional
regulation of PROM1 in patients with STGD4-like MD,
thereby contributing to disease progress. Computerbased protein analysis in different species indicates that
this variant is likely a pathogenic mutation (Table 1).
The damaging consequence on protein indicates that the
variant in PROM1 gene was probably “disease-causing”
with a score of 1 on Polyphen-2 and 0.01 score in scaleinvariant feature transform (SIFT) prediction analysis
(sensitivity: 0.01; specificity: 1.00). Also, Mutation Taster
predicted that the PROM1 heterozygous mutations c.
734T > C (P.L245P) is functionally ‘‘damage-causing’’
(Mutation Taster score is 98). I-Mutant3.0 (stability
predictors, DDG < 0 (decrease stability) and DDG > 0
(increase stability)) showed the variant decreased stability
with a score of -1.59 kcal/mol (Table 1).

Mutation identification and segregation analysis
Targeted exome sequencing (TES) was analyzed
using a genomic DNA (gDNA) sample of the proband
(pedigree II:2) from the STGD4-like MD affected Chinese
family. In total, more than 10 million bases of the sequence
with a 100-bp read length were generated, and 99% of
the bases passed the quality assessment. However, 40,000
single nucleotide polymorphisms (SNPs) and Insertions/
Deletions (INDELs) were found. Then, 99% of the billion
bases were aligned with the human reference sequence,
which had billions of bases covered by a 40-fold coverage
target region. As the data was filtered, we excluded known
variants recorded in dbSNP137, 1000 genomes project,
and HapMap with minor allele frequency (MAF) > 0.50%.
Next, the missense mutations in the PROM1 gene were
selected for segregation analysis and conformational
Sanger sequencing (Figure 2). We identified a novel
heterozygous missense mutation (c.734T > C) of PROM1
gene (NM_006017) (depicted in Figure 1A with pedigree
II:2 and IV:2, respectively; Figure 2A-2B), leading to a
change of amino acid from Leu to Pro at the 245th position
of PROM1 protein (p.L245P). The c.734T > C variant was
consequently validated based on its absence in unaffected
family individuals and unrelated normal controls (100
individuals), which consisted of normal people without a
family history of eye disease (wild type, depicted in Figure
1A with pedigree IV:1; Figure 2C). This variant was
confirmed by Sanger sequencing and it showed complete
segregation in this pedigree M107 family association
furthering population studies and pinpointing its role in
STGD4-like MD pathogenesis.

www.impactjournals.com/oncotarget

Quality check of constructed model
Our homology modeling results were evaluated to
choose the best constructed model for other processes.
The overall quality of the model was further checked
using ProSA-web server, then the Z-score of the models
were calculated. The 3D model was accepted based on
the standards of the ProSA-web server. The ProSA-web
Z-score is an indicator of the overall quality of a model. In
this regard, ProSA-web Z-score of the studied model was
negative and within the range of -4 to -4.30, indicating it
has desirable qualities (Supplementary Table 1). Further
confirmation of the 3D models was performed using
quantitative model energy analysis (QMEAN) tools,
supporting the quality for the model (Supplementary Table
1). Scoring function was assessed based on geometrical
analysis using QMEAN Z-score for all modeled structures.
125
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Figure 2: Sequencing results of the (c.T734C:p.L245P) PROM1 mutation. A. The novel heterozygous missense mutation

(PROM1: NM_006017: exon7: c.T734C:p.L245P) of PROM1 gene in proband (II:2). B. Sanger sequencing results of IV:2 identified as a
wild type. C. The wild type IV:1 was validated in the unaffected family individuals and unrelated normal controls, with the normal male
from no eye disease history family (III:1). All number were depicted in Figure 1. The arrows indicate the mutation at the nucleotide position
c. 734T > C in the PROM1 gene.
www.impactjournals.com/oncotarget

126

Oncotarget

This result shows the quality of constructed model based
on the template including 0.3 to 0.4.

calculated. We investigated the structural and functional
consequences of the reported deleterious point mutation as
an active site domain of PROM1 during a 130 nanosecond
(ns) molecular dynamic simulations phase (Figure 3).
The RMSD values of the PROM1 backbone atoms in the
entire molecular dynamic simulation trajectory (130 ns)
are shown in Figure 3A. As seen in this figure, the wild
type equilibrates after 25 ns with the structure maintaining

Results of molecular dynamic simulation analysis
To evaluate the structural deviation of both wild and
mutated residue during the simulation, distributions of root
mean square deviation (RMSD) of backbone atoms were

Figure 3: Functional effects of the c.734T > C mutation on the PROM1 protein. A. RMSD plots of the wild-type and the

L245P complex systems for 130 ns of simulation, where time step is plotted on X-axis while RMSD (nm) is plotted on Y-axis. B. Difference
in average Cα-RMSF of the L245P mutant (red) and the wild type (blue). The maxima differences of residue-level displacements and
fluctuations of both systems are shown in the residues numbers 70-77 and 183-191. C. The secondary structure as a function of the
simulation time for two model structures. Upper and lower panels indicate secondary structure for the wild-, and -mutant type in the two
main functional extracellular domains of PROM1 protein, 70-77 (upper panel) and 183-191 (lower panel) amino-acid residues, respectively.
This finding indicates the initial structure of PROM1 in the wild type showing as a turn structure while the L245P mutant converted to an
alpha helix during the simulation time (residues number 70-77) (upper panel). Secondary structure analysis in the residues number 183-191
shows this position including a turn conformation at the end of simulation in wild type, whereas the L245P mutant depictes an alpha-helix
during 90 ns and all structures finally returned to the initial conformation at the end of simulation times. D. 3D structure from the wild
type and the L245P mutant of PROM1 represent in gray and red color, respectively. Substitution of the Leu with Pro changes the α-helical
structure of bHLH-Zip domain. The position of the p.L245P mutation is reported in blue color on the both structures. E. Far-UV CD spectra
of secondary structure analysis of the wild and the mutant PROM1 during 130 ns-MD simulations. The two minima at 195 and 210 nm
indicate an α-helical structure.
www.impactjournals.com/oncotarget
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Table 2: Assessment of the Ramachandran plot of the wild and the L245P-mutant type.
Favored
region (%)

Favored a.a. Allowed
number
region (%)

Allowed a.a. Outlier region (%) Outlier
number
number

Wild-Type

72.9

183

19.9

50

7.2

18

L245P Mutant

74.9

188

18.7

47

6.4

16

a.a.

Abbreviations: a.a: amino acids; L245P, Proline substitution conserved leucine at codon 245.
a level of 30 Å, whereas the mutant variant shows a
significant decrease (P = 0.031) in the RMSD value with
more ﬂuctuations containing low stabilization, which has
an average of ≈ 12 Å. During the simulation, the L245P
mutant backbone atoms were aligned with RMSDs of less
than 20 Å, however ﬂuctuations were remarkably visible
over the course of simulation.

We also calculated the residue-based root mean
square fluctuation (RMSF) differences between each
amino acid of PROM1 to directly gain insights into the
structural fluctuation and flexibility of this point mutation;
details are shown in Figure 3B. We found that the L245P
point mutant protein has different fluctuation patterns than
the wild-type protein. The RMSF graph clearly shows that

Figure 4: Tertiary structural stability of the (c.734T > C) p.L245P mutant PROM1. A. Structural superposition of the wild-

(red) and the mutant-type (blue) domains extracted from the trajectories of 20, 80, and 100 ns. The mutation of L245P and the residue
Leu245 of wild type are labeled in green color. The helices and hinge indicate with arrows. α1: residues number 70-77, α2: bHLH-Zip
domain, and α3: residues number: 183-191. B. Plot of average RG values for each of the systems. RG for L245P mutant and wild type
are colored as red and blue, respectively. The chart also shows differential RG values between residues of WT and mutant forms. There
is a strong prospect that the L245P mutation influences the structure of the active site of PROM1, possibly by creating a further fold and
destabilizing the mentioned domain. C. Comparative diagram depicting Ramchandran plot analysis of PROM1 protein variants in the wild
type (upper panel) and the L245P mutant (lower panel) during 130 ns molecular dynamic simulations. Ramachandran plots show the phi
(φ)-psi (ψ) torsion angles for the related residue number 245 of PROM1 in this structure. Leu and Pro residues are shown as square (□)
and are not restricted to the regions of plots. In the upper panel, before mutation, Leu245 located in the 310 helix region, whereas mutated
residue (L245P) transferred to the alpha helix parts of plot in the lower panel during the simulation time.
www.impactjournals.com/oncotarget
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Table 3: Prominent residue contributing towards motions of the wild and the L245P-mutant across different modes.
Mode No.
Residue numbers with highest mobility
1
71, 74, 167, 168
Wild-Type
2
120
3
59, 166, 174
1
252, 170, 168, 165
L245P Mutant
2
67, 78, 82, 83, 65, 86, 93, 228, 243, 245, 250
3
65, 67, 78, 82, 86, 90, 228, 243, 245, 250
Abbreviations: L245P, Proline substitution conserved leucine at codon 245.
mutant variant has significantly higher ﬂuctuations in the
side chain residues from number 70 to 77. To understand
the nature of these structural alterations, secondary
structure assignments for all protein entries were
performed using a defined secondary structure of protein
(DSSP) algorithm [23]. Results from DSSP analysis
confirmed these regions (residues number 70-77) in the
structure generated during the simulation; furthermore,
it revealed that the loop in the initial human PROM1
structure folded into a small helix after the molecular
dynamic simulation (Figure 3C-3D). In contrast, the
simulated wild complex C-alpha atoms have more
ﬂuctuations in the 183-1910 residues number compared
to mutant type (Figure 3B). This result indicates that the
initial structure of PROM1 in wild type exhibits turn
structure while L245P mutant is converted to alpha helix
during 90 ns, before all structures returned to the initial
conformation at the end of simulation times. Therefore,
both RMSF and RMSD results demonstrated the L245P
mutation markedly influences the structure of the active
site of PROM1. Circular dichroism (CD) server was used
for analyzing secondary structure of the wild-type and
mutant PROM1 in the wavelength of far-UV i.e., 195260 nm (Figure 3E). This graph clearly shows that the
secondary structure of L245P mutant system is a more
dominant alpha helix than that in the wild type with two
minima around 195 and 210 nm, contributing to the stable
structure of bHLH-ZIP domain of L245P mutant system.
To further study the evolution of the tertiary
structural stability in a molecular dynamic biological
system, we measured the structural alterations of the
proteins during the simulation. For more details, the
tertiary structural superposition of the wild type (red)
and mutant (blue) were extracted in 20, 80, and 100 ns
of simulations. In the wild-type simulation, the helices
α1 (residues number 70-77), α2 (bHLH-Zip domain) and
α3 (residues number 183-191) maintained their structures
along the entire trajectory, whereas L245P mutant
structure (compared to wild type conformation) exhibited
a higher degree of flexibility, especially at position α2
and α3. It seems that this fluctuation is associated to the
hinge region. In the mutant domain, it appears that helices
α2 and α3 are partially folded so that they are displaced
from its original position, thereby affecting the relaxation
in the bHLH-Zip of the active domain core (Figure 4A).
www.impactjournals.com/oncotarget

To examine the size of protein structure, we plotted the
radius of gyration plot for the C-alpha atoms of protein
versus time, shown in Figure 4B, where it is defined as
the mass-weight root-mean-square distance of collection
of atoms from their common center of mass. This provides
an insight into the overall dimension of the protein. The
Rg of each compound remains stable after 30 ns molecular
dynamic simulation. The average values of the wild type
and L245 mutant group are 2.16 ± 0.31 Å and 2.62 ± 0.32
Å, respectively. Considerable increases in the Rg values
showed about 23% for the mutant, indicateing the stability
of the mutant compared to the wild type, especially in
the hinge region of bHLH-Zip. Thus, stable Rg values
along the trajectories indicate that the overall packing
of bHLH-Zip is maintained during simulations. These
events lead to unstable moments of inertia in the mutant
(Figure 4B). Another approach to analyze the protein
dynamics is to examine the hydrogen bond formation
between all residues, which is considered as a major
force in controlling the stable conformation of protein
structure. This result is shown as in Supplementary Figure
2. The mutant exhibited slightly lower total hydrogen
bond interactions during 130 ns compared to the wild
type. These results confirmed the instability of the overall
mutant structure.
The Ramachandran plots of the wild and L245P
mutant types are provided in Figure 4C and Table 2. They
showed that 19.9% and 18.7% of residues of the wild and
L245P mutant types were placed in the allowed regions,
respectively. This difference between wild and mutant
systems is not as drastic, indicating the slight stabilization
of the optimized human PROM1 structure. The residues
located in the favored zone were also increased from
72.9 to 74.9 during the molecular dynamic simulation. As
shown in Figure 4C, the residue of the wild type (L245)
falls in 310 helix regions of the Ramchandran plot (upper
panel), whereas, after Pro245 substitution, the new residue
is transferred to the alpha helix parts of the plot (lower
panel). This provides evidence to further confirm the
results of DSSP and secondary structure prediction.
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Structural effects on the p.L245P mutation in
residue interaction networks

within the network in comparison to the wild type, which
made a more stabilized bHLH-Zip mutant structure in the
extracellular domain of PROM1. Even so, L245P mutation
affects the interactive network and the overall structure
of the protein, leading to instability of the total structure
of PROM1 protein. Hydrogen bonds in the overall
structure of the wild type are slightly increased compared
to the mutant type. Nevertheless, the specific hydrogen
bond interactions in the mutated region were enhanced
relative to the wild residue (Supplementary Figure 2),
demonstrating that bHLH-Zip domain of the mutant type
is more stable compared to the wild type.

The residue interaction networks (RINs) analysis
of a protein backbone is a new strategy that identifies
key residue interactions. The RINs assays can be used
to explore the differences between different proteins,
including the proteins of the wild type and mutants. In
this work, we investigated the relationship between key
residues of the wild type and that of the L245P mutant
by generating RINs and using representative structures
from 130 ns of molecular dynamics (Figure 5). Evident
from the RINs plot, comparison between the predicted
key residues of the wild type Leu and that of mutated
Pro in the 245th position revealed that the mutant residue
changed the interaction within the network. In the wild
type, the residue Leu245 forms one hydrogen bond with
residue Glu249 (Figure 5A), whereas the mutant form
exhibits that the Pro245 has the two hydrogen bonds with
Leu 248 and Glu249. Also found in the mutant form of
PROM1, the α-helical structure in the bHLH-Zip domain
was noticeably stabilized through close atom interactions
of Pro245 with Ile241, His242, Asn69, Val73, and Leu248
(Figure 5B). In contrast, there are no interactions of
Leu245 with Ile241, His242, Asn69, Val73, and Leu248
in the wild-type system. As a result, analysis of RINs
shows that the mutant residue changed the interaction

The p.L245P mutation of PROM1 dynamical
properties increases fluctuation, flexibility and
atomic density distribution
To detect main dynamical topographies of the
wild-type and the mutant domains as well as highlight
major conformational changes between the structures,
we mathematically investigated the atomic positional
fluctuations covariance matrix of the C-alpha atoms
using the PCA method (Figure 6). In this study, two
principal motions were considered to evaluate the general
fluctuations; the first principal motion (PC1) corresponding
to the scissoring motion between the interacting residues,
and another one (PC2) indicateing a twisting motion.

Figure 5: Residue interaction networks. A. RINs of the active functional extracellular domain residues of PROM1 position in the

wild type and B. the L245P mutant forms. Wild type reported on H-bond with Glu249 and no closely atomic interaction with the surrounding
residues. L245P mutant form shows two H-bond interaction with Leu248, Glu249, and several closer atomic interactions generated through
Pro245 with Ile241, His242, Asn69, Val73, and Leu248. The more interactions between the L245P mutant and neighboring residues could
be destabilized at the bHLH-Zip domain in 130 ns.
www.impactjournals.com/oncotarget
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Figure 6A shows a scatter plot constructed for the wildtype and L245P mutant in both types’ eigenvectors, PC1
and PC2. As shown in Figure 6, the most fluctuations
between all atoms of wild and mutant types are between
-1.088 to 1.88 and -0.95 to 2.96 nm, respectively during
the simulation. It means that the L245P mutant generates
more scissoring motion along the PC1 axis relative to
the wild type. A significant difference between these two
systems are evident from the characteristic structures
plotted along two principal components directions. The
motions of the loop in both systems were described. PCA
revealed that the L245P mutant inhibits a relatively wider
phase space and shows higher fluctuation in contrast to
the wild type. This result is congruent with the presented
Rg graph. The molecular changes were depicted in the
atomic density distribution plot (Figure 6B-6C). There was
a clearly, significant change in the density distribution of
the native compared to the mutant. Moreover, the mutant
structure shows higher atomic density distribution relative
to the wild structure. Also, the L245P mutant complex
occupies a larger phase space and exhibits a higher

fluctuation compared to the wild-type complex. The crosscorrelation matrix and a graph of the correlated and anticorrelated motions in the wild type and mutant system
are shown in Figure 6B-6C, respectively. These results
indicate that a specific residue is established with all the
other residues during 130 ns simulation. Specifically, the
single mutation of L245P mutant causes a change in the
profile of the cumulative correlation motions localized
along the entire bHLH-Zip domain. This effect indicates
that a partial folding of the mutant protein region has
mostly anti-correlated motion, which is primarily involved
in interactions with other domains.
Illustrated by the porcupine plots, alterations in
the direction of residue domain for motion could provide
information about the residue dynamics of the related
regions in the protein during the simulation. Generally,
the first three normal modes indicate the overall motion
represented by the macromolecules during a simulation.
We analyzed the motion modifications between two
systems i.e., wild and L245P mutant along different modes
1, 2 and 3 (Figure 7). The results show that the overall

Figure 6: Dynamical effects of the p. L245P mutation on the PROM1 protein. A.. PCA scatter plots along the pair of first two

principal components, PC1 and PC2 for the wild-type and the L245P mutant showing differences between both types of eigenvectors. This
represents optimal two-dimensional projections of the data over the 130 ns molecular dynamic trajectories. B. Cross correlation matrix
C-alpha atomic graph and plot in during 130 ns simulation for the wild and C. the mutant systems. The range of motion is indicated by
various colors in the panel. Red indicates positive correlation, whereas blue indicates anti-correlation. Totally, the L245P mutant effected
a partial folding of the mutant protein region have the mostly anti-correlated motion; which is primarily involved in the interaction with
other domains. These molecular changes were clearly depicted in the atomic density of distribution plot. There was a significant change in
density distribution in native compared to the mutant. Moreover the mutant structure (L245P) shows highest atomic density distribution
relative to the wild structure.
www.impactjournals.com/oncotarget
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motion between two systems, as shown by the graph, is
wide-ranging and different. In comparison, most motion
between the wild type and L245P mutant systems was
caused by residues number 183-191 and 250-255 across
mode 1, graphed in the Figure 7A. A higher mobility
frequency was observed in the residues number located
at 120-180 and 250-255 in mode 2. Residue behavior at
these positions is emphasized at the partial opening of the
mutant and complete closing of all parts of the wild type.
This observation was also seen in the residues number 50100 and 230-255 of mode 3. Evidently, residues number
70-77 and 183-191 also played significant roles in the
secondary structure modifications of the mutant systems.
These results are consistent with the RMSF plot, in which
the mentioned regions are highly vibrant compared to the
other locations. Most of the motions for the wild type were
due to residues number 150-180 across all three modes
as shown in Figure 7B. The wild type shows a twisting

motion from C-terminal to N-terminal based on the
direction of the residue movement in all parts of protein.
Furthermore, the direction of the above residues number
points toward the center of the active site spatially in
the bHLH-Zip domain, thus creating a suitable location
in the membrane to launch several signaling cascades.
Table 3 highlights the list of residues that attributed to
the majority of motions across different normal modes
in wild and mutant types. As enumerated in Table 3, the
residues with the highest motion include number 70-90
and 220-250 especially at position 245th. These situations
are more mobile than the wild type across three normal
modes. These results are consistent to the Figure 4A,
which showed higher motion in the α2 region i.e., bHLHZip domain.
Dynamically, all these projections show that the
mutant complexes have high values, signifying a large
increase in the flexibility in comparison to the wild

Figure 7: Mobility effects of the p. L245P mutation on the PROM1 protein. A. Residue based mobility plots of the wild and

mutant showing mobility at different residues across different modes. B. Porcupine plots in the three different modes of the wild type
(blue) PROM1 protein. This graph shows the number of residues 70-77 and 183-191 playing significant roles in the secondary structure
modifications of the mutant form. C. Motion in the three different modes of the L245P mutant PROM1 protein. Arrows in blue, green,
and red indicate motions along mode 1, 2, and 3 respectively. These figures clearly show that the L245P mutation affected the overall
conformational fluctuation of the system. Our results indicate the most motions in mode 1 located in residues number 183-191 I. and 250255 (II) (mode 1), 120-180 (III) and 250-255 (IV) (mode 2), as well as 50-100 (V) and 230-255 (VI) (mode 3).
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complex during the collective motion of the PROM1
protein; this pathogenic and deleterious mutation made
the PROM1 protein less stable compared to the wild type
protein complex (Figure 7B-7C).

8B). These figures show that the L245P mutation affected
the overall conformational stability of the system. These
energy levels induced instability in the general structure
of the protein. Thermodynamic profile analysis in Figure
8 indicates that longer population of conformations had
higher energy in the L245P-mutant (0-14.5 kcal/mol)
compared to native type. This observation is consistent
with previous PCA scatter and the porcupine plot, further
supporting that the L245P mutant decreases the stability.

The L245P mutant induces instability in free
energy landscape
To assess the individual amino acid contribution
to the total free energy profile in a simulation between
the wild and L245P mutant, the interaction energy for
the previously mentioned residue was carried out using
GROMACS package by principle component analysis
(PCA). As shown in Figure 8, energy distribution is a
centralized form, indicating the overall conformational
stability of the system. However, the highest mobility and
fluctuation were observed in the L245P mutant, which
was depicted as the higher FEL. The lowest energy for the
wild type system was found to be 0.113 kcal/mol (Figure
8A), while the mutant variant was 0.605 kcal/mol (Figure

DISCUSSION
In this genetic analysis study, we performed TES
arrays to identify the genetic defect in a Chinese family
with multi-cases of STGD4-like MD retinal degenerations
(M107). Using this approach, we successfully identified
a novel c.734T > C (p.L245P) PROM1 heterozygous
mutation. Our findings highlighted that the variant in the
PROM1 gene was likely a deleterious and disease-causing
mutation in this M107 family, thereby expanding the
PROM1 mutation spectrum for STGD4-like MD. Then,

Figure 8: Free energy landscape (FEL). Projections of FEL of the wild A. and the L245P mutant PROM1 B. conformational

space onto PC1 and PC2 produced from PCA. The dark blue indicates the lowest energy configuration and red shows the highest energy
configuration. These energy levels induce the instability in the general structure of mutated protein. This observation is consistent with the
PCA scatter and the porcupine plot.
www.impactjournals.com/oncotarget
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the protein structure-based virtual screening analysis was
performed to identify the protein structure and function of
c.734T > C (p.L245P) mutant. Furthermore, atomic level
study was performed by molecular dynamic simulations
to better understand the effects of the deleterious variant
on p.L245P in active site domain of PROM1. The
computational prediction methods’ results clearly showed
that a novel PROM1 heterozygous mutation significantly
affects the protein structure and function, including
fluctuation, flexibility, atomic density distribution, and
stability.
Despite extensive investigations on STGD4-like
MD, the details of its etiology and pathogenesis remain
unclear. Familial, identical, and adoption studies have
consistently recommended that genetic variation is the
most important general factor, which would be an indicator
of its high heritability [2, 24-29]. Clinical variability exists
in the STGD-like MD, even the same gene of different
point mutations can cause variance phenotypes [30];
importantly, different genes caused the STGD-like MD,
examples include families with ELOVL4 mutation, ABCA4
mutation, and PROM1 mutation [4, 5, 9, 10, 12, 18-20,
22]. In general, the STGD4-like MD is juvenile-onset MD
that is generally related to an ELOVL4 mutation following
PROM1. But, most STGD-like MD subjects maintained
normal vision until the sixth decade of life. This gradually
progressive disease is diagnosed with photophobia,
paracentral scotoma, slow dark adaptation, and loss
of color and central vision. Symptoms and prevalence
of STGD-like MD are the same in altered individuals;
members of the same family can show variations in the
course of the illness [11]. Clinically, it is hard to predict
or screen exactly when the disease will be evident and
how fast it will develop, according to marked phenotype
variability. It is well established that TES is a costeffective and an expedited approach to screen and identify
pathogenic mutations responsible for inherited disorders
on a large scale in comparison to other genetic methods
[31, 32]. This is a predominantly accurate technique when
the study conditions are particularly heterogeneous, as in
a STGD-like MD [33]. By helping to advance imaging
techniques, we have been able to further characterize this
disease [34].
For the first time ever, this study characterized the
novel pathogenic mutation in three-dimensional protein
structure, analyzing this change at the structural level. Our
findings show that c.734T > C (p.L245P) is functionally
damaging and the disease-causing mutation in protein;
therefore, we introduce it as a candidate for further
clinical precision diagnosis and interpret that the same
gene mutation leads to varying onset at different ages, a
characteristic that is clinically useful for early prevention.
It has been widely accepted that the computational
and theoretical methods such as molecular dynamic
simulation, PCA, FEL, and RINs analysis (with parameters
of molecular dynamic to describe motion, stability and
www.impactjournals.com/oncotarget

intercellular binding, respectively) can be used to detect
and investigate the effects of lethal polymorphisms on the
function and structure of protein [35-40]. Understanding
protein conformational changes properly can elucidate
the mechanisms underlying MD disease phenotypes for
designing suitable drugs and medical managements. In
this study, these methods clearly explained the impact
of the mutation on the active site of the PROM1 protein,
before undertaking further validation by experimental
methods. Mutation of the residue alters the overall active
site energy by ~ +6.25 kcal/mol and affects the landscape
of the protein and atomic interaction of key residues. The
different molecular dynamic parameters such as RMSD,
RMSF, DSSP, and Rg index confirmed that the p.L245P
pathogenic mutation changes the molecular stability and
flexibility as well as the amino acid interaction network
and 3D conformational landscape. Interestingly, hydrogen
bond interactions and van-der Waals forces of Pro245 with
His242, Val73, Asn69, Leu248, Glu249, and Ile241 in the
α-helical structure of bHLH-Zip domain significantly
increased to maintain a stable contact of the mutant form
of PROM1, whereas total protein stability was reduced due
to fluctuation in the hinge region of the mutated structure.
The substitution of deleterious L245P mutation might
change the electrostatic charge distribution in proteins and
affect normal interactions. From this analysis, we suggest
that the mutated PROM1 domain has drastically decreased
functionality and stability capacity as a consequence of
the partial unfolding of the α2/α3 helices in the bHLHZip domain. This mutation led to a change of a neutral
amino acid residue, Leu, to a nonpolar charged residue,
Pro, located at the basic repeating unit of the bHLH-Zip.
The Leu position in bHLH-Zip plays an essential role in
transcriptional regulation of PROM1 [41]. It is likely that
the substitution may impair protein stability and proper
function, leading to the STGD4-like MD disorder [42].
The Pro mutation in the bHLH-Zip domain may destroy
the PROM1 transportation [43], a phenomenon possible
and consistent in our patient’s observation. Consequently,
this instability and inflexibility affected the main function
of PROM1 in the plasma membrane invaginations and
disk malfunction, trapping it in the myoid region of
the photoreceptors. Functionally, the PROM1 protein
is necessary for disk formations in the photoreceptor
cells. PROM1 has an influence on the formation and
organization of disk within the photoreceptors. Mutations
in PROM1 gene would trap PROM1 in the myoid region
of the photoreceptors, preventing it from migrating to
the site that formed disks. Accordingly, abnormalities in
PROM1 positions in the photoreceptors cells will lead
to disk malfunction. Previous studies have shown that
different mutants undergo different misfolding pathways
and exhibit different pathogenesis according to the
different MD-related diseases [10, 12, 18-20]. In addition
to an autosomal recessive PROM1 early-childhoodonset retinopathy, an autosomal dominant later-onset
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DNA sampling

macular retinal phenotype has been documented in some
individuals heterozygous for PROM1 mutations [18, 44],
including in our study.
To the best of our knowledge, this is first report
that identified and characterized a novel c.734T > C
(p.L245P) mutation of PROM1 with STGD4-like MD
using the TES and multiple molecular dynamic analyses.
The findings clearly confirmed that the variant in the
PROM1 gene is most likely the deleterious and diseasecausing mutation in our studied family. While variants
with incomplete segregation would be regarded as low
to moderated penetrance effectors, complete segregation
of a one novel variant (in PROM1 gene) demonstrates
the variants are noteworthy candidates in case-control or
population studies; however, it warrants more extensive
studies of the PROM1, including in various ethnic groups.
Altogether, this study provides compelling evidence
that the PROM1 gene mutation should contribute to the
progressive causativeness or susceptibility in patients
with STGD4-like MD, as well as defines a new approach
into the genetic characterization, precision diagnosis and
prevention for STGD4-like MD disease.

Peripheral blood samples in the pedigree M107
family and unrelated ethnically matched healthy control
volunteers with no family history of this disorder were
collected. gDNA was extracted from peripheral blood
lymphocytes according to the standard phenol-chloroform
method [45]. The DNA quality was measured by a
NanoDrop-2000-spectrophotometer. High quality intact
genomic DNA with optical density ratio of 260/280~ 1.8
and 260/230 > 1.5 were used for further analysis.

Design of exome capture panel
Illumina paired-end libraries (Illumina, Inc.,
San Diego, CA) were generated according to the
manufacturer’s sample preparation protocol for gDNA [46,
47],. TES on an affected family member was randomly
sheared by sonication into fragments of about 300-500
bp and then hybridized to the precapture libraries, which
were quantified (PicoGreen fluorescence assay kit; Life
Technologies, Carlsbad, CA); their size distributions were
determined by a commercial bioanalytical system (Agilent
2100 BioAnalyzer; Agilent Technologies, Santa Clara,
CA). For each capture reaction, fifty pre-captured libraries
(60 ng/library) were pooled together. Hybridization and
wash kits (Agilent Technologies, Santa Clara, CA) were
used for the washing and recovery of captured DNA
following the standard manufacturer’s protocol. Captured
libraries were quantified and sequenced (Illumina HiSeq
2000; Illumina, Inc.) as 100-150 bp paired-end reads,
following the manufacturer’s protocols whitch performed
at the BCM-FGI core. More than 99% of the targeted
coding exons were covered by at least 10 folds nonredundant sequencing reads.

MATERIALS AND METHODS
Ethical consideration, patient information, and
clinical assessment
The study was approved by the Ethical committee of
Southwest Medical University according to the Helsinki
Declaration (1983 Revision) [45]. The cases were coded,
and measurements were made in a blinded fashion by
molecularist.
A four-generation, 18-related Chinese patients
(M107) with familial STGD4-like MD was recruited.
The genetic and full pedigree structures of the subjects
are shown in Figure 1A. The patient proband claimed
to have eye problems since the age of 42. All patients
were diagnosed with STGD4-like MD by an experienced
ophthalmologist; we also documented the patients’
inheritance patterns, ethnicity and summary information
regarding the numbers of affected subject and members
who were available for sampling. We obtained medical
history and standard ophthalmologic examinations
including best corrected visual acuity measurements,
slit-lamp biomicroscopy, and color vision tests in all
available family members. In addition, FP, FA (Spectralis;
Heidelberg Engineering, Heidelberg, Germany), visual
field tests (Carl Zeiss, Germany), and retinal structure
were examined by OCT (Carl Zeiss, Germany). ERGs
were performed using corneal “ERGjet” contact lens
electrodes (RetiPort ERG System; Roland Consult,
Wiesbaden, Germany) [45]. The ERGs protocol complied
with the standards published by the International Society
for Clinical Electrophysiology of Vision.
www.impactjournals.com/oncotarget

Variant filtering and homozygosity mapping
After passed quality control (QC) of the illumina
reads ( > 70-80% Q30 data, < 0.5% error rate), BurrowsWheeler Aligner (BWA) V7.10 was used to access
sequence reads to the human reference genome from
available public online UCSC database (http://genome.
ucsc.edu/), version hg19 (build 37.1). Next, recalibration
and local realignment were analyzed using the Genome
Analysis Toolkit (GATK version 1.0.5974), and the refined
sequencing results were subjected to variant calling using
a toolkit (Atlas2). Variant annotation was performed
by applying ANNOVAR. Sequencing depth > 4, the
estimated copy number ≤ 2, SNP quality > 20 (score 20
represents 99% accuracy of a base call) and the distance
between two SNPs > 5 were considered the filtration
criteria for candidate SNPs [48]. We first searched for
known pathogenic mutations in STGD candidate genes
and then variants with a MAF (Minor allele frequency)
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of less than 5% allele frequency in databases of 1000
Genomes Project (1000genomes release_20100804,
http://www.1000genomes.org/). In total, the average of
4000 SNPs and INDELs were found after applying these
filters. Subsequently, the phenotype of all cases was
considered to be similar. At first approach, our focus was
on identifying common variants among affected subjects
between families, but we also identified any shared variant
related to STGD. Consequently, we searched for variants
within STGD-related genes in proband (depicted in Figure
1A with pedigree II:2) separately. The selected variants
were further analyzed in respect to whether they are
homozygous or heterozygous.

were used to analyze the PROM1 conservation in deferent
organism gene by inputting the data into the HomoloGene
software of NCBI “Show Multiple Alignment” and
Jalview software [55].

Homological based modeling
The sequence of human PROM1 was downloaded
from the universal protein resource (http://www.uniprot.
org) (Entry: O43490). The template for sequence
alignment was identified by searching human PROM1
on PDB using the BLASTp program. The 3D structure of
PROM1 (XKD) was created using MODELLER version
9.17 [56], then the model was viewed using PyMol
software [57]. The initial coordinates of PROM1, which
were used in our molecular simulations, were based on
crystal structure of the template protein (PDB Entry:
4wid). A mutation of Leu to Pro at position 245th was
generated in silico from the wild-type crystal structure
using Pymol software [58]. The general streochemical
quality of the final modeled protein structure was
evaluated using PROCHECK [59], ProSA-web (protein
structure Analysis) [60], RAMPAGE, and QMEAN
analysis [61].

Mutant confirmation and segregation analysis
For mutant confirmation and segregation analysis,
we designed locus-specific primers using the online
Primer3 program (http://primer3.ut.ee/) for polymerase
chain reaction (PCR) amplification of prioritized variants
and direct sequencing, upon the gDNAs of family
members. Then, the PCR products were validated and
confirmed by Sanger sequencing methods on an ABI
3500DX sequencer (Applied Biosystems Inc., Foster City,
CA, USA) with the specific primers. Then, all results were
analyzed by Sequencing Analysis v.5.2 software (Applied
Biosystems). All analyses were performed with two
replicates per sample; a non-reverse transcription control
and non-template control for each test. The specific primer
sequences of PROM1 gene variant for Sanger sequencing
are listed in Supplementary Table 2.

Molecular dynamic simulation
Molecular dynamics (MD) simulations investigate
the motions and fluctuations of a system containing
discrete particles under the impact of internal and external
forces. The role of this application base on this method
is broad, ranging from atoms to a molecule. The initial
3D structure made from modeler was optimized using
molecular dynamic simulation. The 130 ns simulations
of p.L245P on the active functional extracellular domain
of PROM1 (position 179-433, Supplementary Figure 3)
were performed using the GROMCS molecular dynamics
package version 5.1.3, which, on the Centos linux system,
implements GROMOS96 package version 43a1 force
field. pdb2gmx tools from GROMACS software package
was applied to generate the topology file. The 3D human
PROM1 was surrounded by a cubic periodic box of the
simple point charge model of water molecules with a
margin of 1.0 Å along each dimension. [62]. In detail,
the number of water molecules in the cubic cage was
approximately 120,000. Also, the molecular dynamical
systematic simulations charges were neutralized by
using sufficient Na+ and Cl- ions. All covalent bonds to
hydrogen atoms were constrained using the SHAKE
algorithm. Electrostatic interactions were calculated
using the particle-Mesh Ewald algorithm [63] with a
cutoff of 10 Å for Lenard-Jones interactions. Periodic
boundary conditions were applied to avoid edge effects.
Prior to molecular dynamic production, 50,000 steps of
steepest-descent minimization were used to the solvent.

Mutation analysis in silico
The damaging effects of heterozygous mutations
(c.734T > C mutation) on PROM1 protein functions
were evaluated in silico using online web server
Mutation Taster (http://www. mutationtaster.org/) [49],
Polymorphism Phenotyping version 2 (PolyPhen-2,
http://genetics.bwh.harvard.edu/pph2/) [50], SIFT (http://
sift.jcvi.org/) [51], Have Your Protein Explained (HOPE)
[52], and PANTHER (http://www.pantherdb.org/tools/
csnpScoreForm.jsp) programs [53]. Functional impact
of the mutation was documented as ‘‘tolerated’’ or
‘‘damaging’’ for SIFT and as ‘‘polymorphism’’ or ‘‘disease
causing’’ for Mutation Taster. PolyPhen-2 classifies
predicted effects of amino acid substitutions, marking
the function of human proteins as ‘‘benign’’, ‘‘possibly
damaging’’, ‘‘probably damaging’’, or ‘‘unknown’’. To
predict stability changes upon mutation from the protein
sequence or structure, I-Mutant3.0 was used based on the
stability predictors (DDG < 0: decrease stability, DDG >
0: increase stability) [54]. Pairwise alignment between
template and target were performed by EBI/EMBL. Also,
NCBI online data bases (http://www.ncbi.nlm.nih.gov/)
www.impactjournals.com/oncotarget
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Analysis of molecular dynamic trajectory

After energy minimization, the system was equilibrated
with NVT (isochoric-isothermal) and NPT (isothermalisobaric) ensembles under the condition of position
restraint for heavy atoms, with 100 ps with gradual
heating from 300 K [64]. In addition, stable salt bridges
were extracted based on a distance cut-off value of 0.4
nm. The atomic coordinates of each model were saved
every 1-ps for the analysis. The temperature and pressure
coupling was applied using the modified Berendsen
thermostat algorithm [65] at 300 K and Parrinello-Rahman
algorithm [66] at 1 atmosphere with a link constant of 0.1
ps and time duration of 100 ps. The comparative analyses
were saved every 1 ps time interval for further analyses,
including RMSF for all human PROM1 structures.
RMSD, secondary structure modifications, Rg, hydrogen
bond occupancy, secondary structure analysis, PCA,
and clustering analysis were performed for the wildtype and mutated form [67]. Additionally, the structural
changes were visualized using VMD version 1.9.2 and
Pymol software. The plots were conducted using xmgrace
tool and secondary structure analysis, by DSSP of the
GROMACS packages, respectively. Furthermore, a 130 ns
molecular modeling trajectory of the system was obtained
under constant pressure at 300 K using the GROMACS
software package.

The trajectory files were analyzed using gmx rms,
gmx rmsf, and gmx gyrate GROMACS utilities to obtain
the RMSD, RMSF, and Rg. The numbers of distinct
intermolecular hydrogen bonds formed between all
residues during the simulation were calculated using gmx
hbond utility. Secondary structure analyses using DSSP
module were performed for both the wild type and L245P
mutant over the whole simulation period.

Circular dichroism spectroscopy analysis
The secondary structure of the wild-type and
p.L245P mutant system were determined by CD
spectroscopy during 130 ns modeling using DichroCalc
server [69]. CD spectroscopy is a well-established
technique for measuring the secondary structure,
dynamics, and folding pathways of proteins in the “farUV” spectral region (190-250 nm); where alpha-helix,
beta-sheet, and random coil structures each give rise to a
characteristic shape and magnitude of CD spectrum [70].

Principal component analysis (PCA)

Residue interaction networks of the wild- and
mutant-type

PCA is a method that reduces the complexity of the
data and extracts the concerted motion that are essentially
correlated and presumably meaningful for biological
functions during simulations. PCA was performed to
determine the correlated motions of the residues to a
set of linearly uncorrelated variables named principal
components that are significant for the biological function
of the protein during the course of simulation [38]. In PCA
analysis, a variance/covariance matrix was constructed
from the trajectories after the removal of the rotational and
translational movements. PCA is a widely used protocol
to simplify eigenvectors and eigenvalues of bio-molecules
from the molecular modeling trajectories by relating it to
the dimensional reduction method. GROMACS utility
tools were used to perform PCA, with using normal mode
wizard of VMD. PCA scatter plots were then created by
the xmgrace program.

To analyze the mutatant residue on protein sequence,
we used the open source software platform, Cytoscape
v3.3.0 [35]. Cytoscape allows us to map the various
interactions of wild- and mutant-type residue sources
data in RIN models. In this regard, the average structure
derived from the 130 ns trajectory of each system, wild
type and L245P mutant was used to construct the RINs
in 2D graphs using RING 2.0 web server [68]. This is a
new version of the RING software for the identification
of covalent and non-covalent bonds in protein structure.
After determining the interaction between amino acids,
RING used several tools to define non-covalent interaction
between the amino acids, including hydrogen bonds, salt
bridges, and interaction in closest atom. We mapped
the information about the protein mutation and natural
variation of a PROM1 protein onto all the corresponding
nodes in the pathway. All the processed residues
(functional extracellular domain of PROM1 in position
179-433) were separately imported into Cytoscape 3.3.0 to
reconstruct amino acidic networks using RINalyzer plugin software [36]. Therefore, the Cytoscape archive files
were constructed by submitting the crystal structure of
both the wild type and the mutant protein to RING server
[37].
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Free energy landscape (FEL)
FEL promotes the dynamic energy distribution
and structure-function correlation of mutational residues
variable in the protein system, which helps to visualize the
stability of wild and mutant conformations for a protein
[39]. The free energy minima regularly characterizes
the conformational group in the stable states. The free
energy barriers represented by the transient states of free
energy values of backbone atoms in different systems,
according the Gibb’s free energy method [40]. In this
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